The Fetal Echocardiogram

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 21/06/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1656 times

2 The Fetal Echocardiogram

Background

As recently as the early 1990s, less than 10% of infants undergoing cardiac surgery in the first month of life received a diagnosis before birth. Today, reported rates of prenatal diagnosis frequently approach 50%.

A variety of maternal or fetal disorders may place a fetus at increased risk for congenital heart disease (CHD) (Table 2-1). If present, a fetal echocardiogram is indicated, and timely referral is recommended. Combined, approximately 5% of pregnancies are referred for in utero evaluation. Abnormal or unsatisfactory (the inability to establish normal) cardiac views obtained as part of an obstetric anatomic survey account for more than 20% of all referrals for in utero evaluation and lead to more than half of all prenatal diagnoses. The anatomic survey, a nearly universal mid-pregnancy ultrasound scan, includes a four-chamber (4C) view of the heart and, if possible, views of both outflow tracts. A positive family history accounts for another nearly 20% of all referrals. However, these are the source of less than 5% of all prenatal diagnoses.

TABLE 2-1 INDICATIONS FOR FETAL ECHOCARDIOGRAPHY

Maternal Indications Fetal Indications
Family history of CHD including prior child or pregnancy with CHD Abnormal obstetric screening ultrasound
Metabolic disorders (e.g., diabetes) Extracardiac abnormality
Exposure to teratogens Chromosomal abnormality
Exposure to prostaglandin synthetase inhibitors (ibuprofen) Arrhythmia
Infection (rubella, coxsackie virus, parvovirus B19) Hydrops
Autoimmune dx (e.g., Sjögren syndrome, SLE) Increased first trimester nuchal translucency
Familial inherited disorder (Marfan, Noonan syndromes) Multiple gestation and suspicion for twin-twin transfusion syndrome
In vitro fertilization  

Cardiac Embryology and In Utero Physiology

Overview

Echocardiography is the main diagnostic modality used to evaluate the fetal heart. The optimal timing for performance of a comprehensive transabdominal fetal echocardiogram is 18 to 20 weeks’ gestation. In select cases, late first trimester evaluation may be possible. Evaluation late in gestation is often complicated by a more “fixed” fetal position, which may limit the available acoustic windows.

A complete fetal echocardiogram includes two-dimensional (2D) evaluation of cardiac anatomy, spectral and color Doppler interrogation, and an assessment of cardiac function and rhythm. The components of a comprehensive evaluation are listed in Table 2-2, although not all may be visualized in every fetus at every examination. Similar to transthoracic imaging, fetal echocardiography depends on the ability to obtain standard views and evaluate structures in orthogonal views. The fetus may be very active, and the examiner may need to piece together many partial images to form a composite picture, particularly in the presence of complex CHD.

TABLE 2-2 COMPONENTS OF THE FETAL ECHOCARDIOGRAM

Overview

Biometric examination Cardiac imaging Doppler examination Measurement data Examination of rate and rhythm